Therapie chronischer Ischämieschmerzen bei peripherer arterieller Verschlusskrankheit

Rüger, L. J.; Irnich, Dominik; Grasmueller, S.; Lang, Philip M.

doi:10.1007/s00482-007-0556-1

Cited by 2 publications

(1 citation statement)

References 18 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Based on our experience, a multidisciplinary team approach to manage the chronic ischemic pain is vital, since different specialties have different therapeutic options for the treatment of chronic ischemic pain [ 86 ]. Moreover, no single specialty is able to manage all aspects of the patients with diabetic CLTI.…”

Section: Intervention Of Pain Management In Cltimentioning

confidence: 99%

Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia

Jiang

et al. 2021

Journal of Diabetes Research

View full text Add to dashboard Cite

Management of neuropathic pain in people with diabetes has been widely investigated. However, little attention was paid to address ischemic-related pain in patients with diabetes mellitus who suffered from chronic limb-threatening ischemia (CLTI), the end stage of lower extremity arterial disease (LEAD). Pain management has a tremendous influence on patients’ quality of life and prognosis. Poor management of this type of pain owing to the lack of full understanding undermines patients’ physical and mental quality of life, which often results in a grim prognosis, such as depression, myocardial infarction, lower limb amputation, and even mortality. In the present article, we review the current strategy in the pain management of diabetes-related CLTI. The endovascular therapy, pharmacological therapies, and other optional methods could be selected following comprehensive assessments to mitigate ischemic-related pain, in line with our current clinical practice. It is very important for clinicians and patients to strengthen the understanding and build intervention strategy in ischemic pain management and possible adverse consequence.

show abstract

Section: Intervention Of Pain Management In Cltimentioning

confidence: 99%

Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia

Jiang

et al. 2021

Journal of Diabetes Research

View full text Add to dashboard Cite

show abstract

Wiederholte perkutane chemische Sympathektomie als Therapieoption bei peripherer arterieller Verschlusskrankheit II

Gaus¹,

Grabener

Höche

et al. 2010

Schmerz

View full text Add to dashboard Cite

The value of percutaneous chemical lumbar sympathectomy (LSE) for the treatment of peripheral arterial disease (PAD) is still being discussed controversially. In particular, a benefit for Fontaine stage II PAD could not yet be shown. This case report is about a patient suffering from Fontaine stage II PAD. By applying five LSE in regular intervals good symptom control could be achieved and maintained for more than 5 years. The case is an occasion to call for larger controlled studies designed to find out the efficacy of LSE for the treatment of stage II PAD. Mechanisms and available data are discussed.

show abstract

Therapie chronischer Ischämieschmerzen bei peripherer arterieller Verschlusskrankheit

Abstract: The differences among the specialties and the fact that the majority of physicians characterized the available symptomatic treatment options as insufficient point towards a need to review the treatment of ischemic pain in an interdisciplinary approach.

Cited by 2 publications

References 18 publications

Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia

Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia

Wiederholte perkutane chemische Sympathektomie als Therapieoption bei peripherer arterieller Verschlusskrankheit II

Contact Info

Product

Resources

About